{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-22-000044","form_type":"8-K","ticker":"RVTY","cik":"0000031791","company_name":"REVVITY, INC.","filed_at":"2022-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.223477+00:00","generated_at":"2026-06-27T19:06:51.858759+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"PerkinElmer raises Q4 2021 outlook: adj. EPS at least $2.40, non-COVID organic growth ~10%","bullets":["Q4 2021 adjusted EPS expected at least $2.40, above prior guidance.","Q4 non-COVID organic growth ~10%; full-year 2021 non-COVID organic growth ~16%.","Q4 COVID-related revenue ~$320M; full-year COVID revenue over $1.5B.","Full-year 2021 total revenue ~$5.0B: Diagnostics ~$2.9B, Discovery & Analytical Solutions ~$2.1B."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-22-000044","json":"https://secwatch.observer/filing/0001157523-22-000044.json","markdown":"https://secwatch.observer/filing/0001157523-22-000044.md","text":"https://secwatch.observer/filing/0001157523-22-000044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/31791/000115752322000044/0001157523-22-000044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/31791/000115752322000044/a52560227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T19:06:51.858759+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}